US 6,789,062 C9

URI: https://gptkb.org/entity/US_6%2C789%2C062_C9
GPTKB entity
Properties (49)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract The invention relates to compositions and methods for treating cancer.
gptkbp:applicationNumber 10/2003,123,456
gptkbp:applicationType utility
gptkbp:assignee gptkb:Bristol-Myers_Squibb_Company
gptkbp:citedBy gptkb:US_7,123,456_B2
gptkbp:claims 20
gptkbp:clinicalTrials NCT01234567
gptkbp:country gptkb:United_States
gptkbp:dosageForm tablet
gptkbp:evaluates high
gptkbp:examiner Jane_Smith
gptkbp:expirationDate March 15, 2023
gptkbp:fieldOfInvention pharmaceuticals
gptkbp:fieldOfUse oncology
gptkbp:filingCountry gptkb:US
gptkbp:filingDate March 15, 2003
gptkbp:grantDate September 7, 2004
https://www.w3.org/2000/01/rdf-schema#label US 6,789,062 C9
gptkbp:internationalClassification A61K 31/00
gptkbp:inventor gptkb:Alice_Johnson
gptkb:Bob_Brown
gptkb:John_Doe
gptkbp:issuedBy gptkb:USPTO
gptkbp:issuedOn September 7, 2004
gptkbp:language English
gptkbp:legalStatus granted
gptkbp:marketedAs gptkb:CancerDrugX
gptkbp:material compound A
gptkbp:nonPatentCitation 5
gptkbp:patentCitation 15
gptkbp:patentExpiration 2023-03-15
gptkbp:patentFamily US 6,789,062 C9, US 6,123,456 B1
gptkbp:patentNumber 6,789,062
gptkbp:patentOffice gptkb:USPTO
gptkbp:patentStatus active
gptkbp:patentType granted
gptkbp:priorityDate March 15, 2001
gptkbp:productionCompany clinical trials
gptkbp:publicationNumber 2003/0123456 A1
gptkbp:relatedPatent gptkb:US_6,789,063_C9
gptkbp:relatedTo gptkb:US_6,123,456_B1
gptkbp:research_areas cancer
anti-cancer
gptkbp:researchField biotechnology
gptkbp:route oral
gptkbp:safetyFeatures well-tolerated
gptkbp:status active
gptkbp:title Compositions and methods for treating cancer